Proving the business case for a UK population health tool by modelling cost savings

What we did:

Developed a structured evidence strategy to demonstrate the value of a primary care population health solution to NHS buyers.
Validated the client's value proposition through workshops and interviews with senior NHS decision-makers, including Integrated Care Board (ICB) clinical leaders.
Mapped the NHS asthma care pathway, to show where the tool could deliver the greatest impact along the patient journey.
Developed a user-friendly cost calculator to quantify the financial impact of the tool, enabling cost-saving analysis to be localised for any NHS ICB.

Demonstrated a potential net cost reduction of £2.7 million with the NHS.
Equipped the client with an evidence-based narrative to demonstrate how their tool tackles system-level challenges.
Quantified potential savings, showing that actioning as few as 5% of additional patients could achieve break-even.
Delivered a localisable cost calculator, demonstrating ICB-specific potential financial impact.
Provided strategic recommendations to strengthen the business case by aligning the tool with a range of NHS priorities.